Search

everythinglearnresearchcommunity

for

Search:↓

Adolescents with alopecia areata face more bullying and emotional challenges, needing support to improve their quality of life.

Hair loss significantly affects quality of life and mental health, causing anxiety and depression.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

More severe alopecia areata can lower quality of life.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Alopecia areata significantly increases anxiety, depression, and reduces quality of life.

Nepalese patients with hair loss, especially women and those with androgenetic alopecia, experience a significant decrease in quality of life.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

Rosacea severely affects the quality of life for many patients in China, especially young adults and those with appearance-related jobs.

Keloids significantly reduce quality of life, and treating symptoms should be prioritized.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

WAA-QOL measures impact of hair loss on women's well-being.

Alopecia areata affects life quality differently based on its severity.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Wigs greatly improve life quality for hair loss patients.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

People with autism are more likely to develop alopecia areata than those without autism.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Knowing how long skin diseases last is important for better patient care.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

The project highlights the importance of early diagnosis and patient advocacy in managing Systemic Lupus Erythematosus.

Alopecia areata affects women and young adults most, with low SDI regions seeing the highest increase, and new treatments like JAK inhibitors are being explored.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.